The SIK Axis as a Progression Modifier in Lymphangioleiomyomatosis: Nutritional Antioxidant Reserve as a Determinant of Healthy Tissue Survival in the TSC2-Driven Lung Microenvironment

Lymphangioleiomyomatosis is a rare, progressive, almost exclusively female lung disease driven by loss-of-function mutations in TSC2 genes, resulting in constitutive mTORC1 hyperactivation. This paper proposes that the SIK axis applies as a progression modifier in LAM — the rate at which healthy surrounding lung parenchymal cells survive the oxidative microenvironment created by LAM nodules is determined in part by their own selenium-dependent, NRF2-dependent, and CoQ10-dependent antioxidant reserve capacity. All claims are hypothesis-level requiring prospective investigation.